e-Fund completes investment in Mesentech
e-Fund, a British Columbia Venture Capital Corporation (VCC), closed its investment in Mesentech on 24th May 2019. This investment will enable Mesentech to initiate safety trials of a candidate conjugate drug for reversing bone-loss.